How a 3D-printed chemical absorber could pave the way for higher chemotherapy doses – or lower risks.
Jonathan James | | Interview
There is a challenge that oncologists have wrestled with for decades: how to provide patients with higher doses of cytotoxic drugs without potentially life-threatening toxicity. A 3D printed chemical absorber might provide the answer by “mopping up” excess cytotoxic drug before it enters the blood stream, according to a team based in the US (1). Here, we catch up with two of the researchers behind the device – Steven Hetts, Professor of Radiology at the University of California] and Nitash Balsara, Professor of Chemical and Biomolecular Engineering at UC Berkeley– for the background story and to learn their next steps.
Enjoy our FREE content!
Log in or register to read this article in full and gain access to The Translational Scientist’s entire content archive. It’s FREE and always will be!